At a glance
ClinicalIndex Comparison RecordN/ACompleted· 29 enrolled
Drug / intervention
Sculptra new dilutiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study to Evaluate Safety and Effectiveness of Poly-l-lactic Acid (PLLA) for the Improvement in Appearance of Cellulite
In Brief
A clinical study evaluating Sculptra new dilution for Cellulite. Completed, enrolled 29 participants across 1 site.
Detailed Summary
This pilot study has been designed to evaluate the safety and effectiveness of PLLA as a single regimen for the improvement in appearance of cellulite after changes in reconstitution procedure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCellulite
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedOct 2021
Enrollment StartNov 2021
Primary CompletionDec 2022
Study CompletionFeb 2023
TodayJul 2026
First PostedOct 1, 2021
Enrollment StartNov 19, 2021
Primary CompletionDec 21, 2022
Study CompletionFeb 27, 2023
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 4.8 years ago
Interventions
Sculptra new dilutiondevice
Treatment to improve appearance of cellulite.